全文获取类型
收费全文 | 206626篇 |
免费 | 2689篇 |
国内免费 | 160篇 |
专业分类
耳鼻咽喉 | 1431篇 |
儿科学 | 7044篇 |
妇产科学 | 3359篇 |
基础医学 | 20682篇 |
口腔科学 | 2518篇 |
临床医学 | 14371篇 |
内科学 | 38209篇 |
皮肤病学 | 1496篇 |
神经病学 | 18577篇 |
特种医学 | 10090篇 |
外科学 | 34260篇 |
综合类 | 2471篇 |
一般理论 | 1篇 |
预防医学 | 19043篇 |
眼科学 | 3413篇 |
药学 | 11873篇 |
中国医学 | 668篇 |
肿瘤学 | 19969篇 |
出版年
2023年 | 157篇 |
2022年 | 336篇 |
2021年 | 585篇 |
2020年 | 341篇 |
2019年 | 436篇 |
2018年 | 22388篇 |
2017年 | 17768篇 |
2016年 | 19940篇 |
2015年 | 1474篇 |
2014年 | 1523篇 |
2013年 | 1670篇 |
2012年 | 8291篇 |
2011年 | 22409篇 |
2010年 | 19619篇 |
2009年 | 12226篇 |
2008年 | 20700篇 |
2007年 | 22899篇 |
2006年 | 1918篇 |
2005年 | 3601篇 |
2004年 | 4687篇 |
2003年 | 5635篇 |
2002年 | 3732篇 |
2001年 | 1556篇 |
2000年 | 1729篇 |
1999年 | 1355篇 |
1998年 | 602篇 |
1997年 | 539篇 |
1996年 | 391篇 |
1995年 | 384篇 |
1994年 | 344篇 |
1993年 | 300篇 |
1992年 | 858篇 |
1991年 | 806篇 |
1990年 | 859篇 |
1989年 | 778篇 |
1988年 | 765篇 |
1987年 | 665篇 |
1986年 | 638篇 |
1985年 | 632篇 |
1984年 | 412篇 |
1983年 | 346篇 |
1982年 | 173篇 |
1980年 | 171篇 |
1979年 | 321篇 |
1978年 | 216篇 |
1977年 | 154篇 |
1975年 | 154篇 |
1974年 | 232篇 |
1973年 | 152篇 |
1972年 | 165篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
Chad G. Ball Andrew W. Kirkpatrick Matthew Smith Robert H. Mulloy Leonard Tse Ian B. Anderson 《European journal of trauma and emergency surgery》2007,33(5):550-552
Abstract We report a case of SMV injury in a critically ill patient. The patient was a 19-year-old woman involved in a motor vehicle
collision. Her injuries included grade II splenic and renal lacerations, devascularized and lacerated right and transverse
colon, a transected transverse mesocolon, a massive shear injury of her abdominal wall, and two partial SMV transections.
At initial damage control laparotomy, the SMV was ligated, the devascularized bowel resected and a temporary abdominal closure
applied. At re-operation, a mesocaval shunt using saphenous vein was employed. The shunt failed and the patient required a
saphenous vein jump graft. Although visceral vascular injuries are rare, ligation of the SMV in a damage control situation
is acceptable. This case study is the first to discuss appropriate treatment when interruption to a patient's collateral visceral
venous drainage limits the surgeon’s ability to ligate. In these situations, bypass shunts may be successful. 相似文献
44.
Henry Cisneros 《AIDS and behavior》2007,11(2):7-8
For persons battling HIV/AIDS a stable place to live may decide the length and quality of life itself. It is nearly impossible for a person on the streets to engage in a needed continuous AIDS treatment regimen when the very basic question of where that person will rest his or her head when darkness comes in just a few hours is unresolved. When danger lurks on the streets, when cold numbs the limbs, when tiredness overwhelms the mind, when fear breaks the spirit, a place to call home would make all the difference. 相似文献
45.
46.
47.
Background
Reports on childhood cancer survivors estimated cumulative probability of developing secondary neoplasms vary from 3,3% to 25% at 25 years from diagnosis, and the risk of developing another cancer to several times greater than in the general population. 相似文献48.
Alf Lamprecht Hiromitsu Yamamoto Hirofumi Takeuchi Yoshiaki Kawashima 《European journal of pharmaceutics and biopharmaceutics》2005,59(2):367-371
5-Fluorouracil (5-FU) in combination with leucovorin (LV) is nowadays the standard treatment in colon cancer and would be a candidate to be delivered orally to the colon. Eudragit P-4135F or Eudragit RS100 were used separately to prepare microspheres by an oil/oil emulsification process trapping 5-FU and LV simultaneously. Scanning electron microscopy permitted a structural analysis, process parameters were analyzed and drug loading and release profiles were recorded. Particle size varied between 123 (RS100) and 146 microm (P-4135F). Generally, higher encapsulation rates were found with RS100 (5-FU, 60.3+/-9.7%; LV, 81.4+/-8.6%) compared to P-4135F (5-FU, 48.3+/-2.0%; LV, 55.4+/-2.7%). Microparticles made from Eudragit RS100 released the incorporated drug combination within 8 h not exhibiting general differences between the kinetics of both drugs. P-4135F was found to maintain the undesired 5-FU release at pH 6.8 lower than 25% within 4 h while at pH 7.4, a nearly immediate release (within 15 min) was observed. Although the release was similar at pH 7.4, at pH 6.8 LV showed a distinct initial drug loss of about 60% and a complete release within 2 h. SEM analyses revealed a substantial presence of LV crystals on the particle surface provoking a distinct burst effect of LV. These observations were concluded to be related to the high lipophilicity of P-4135F provoking a separation between P-4135F and LV during the preparation process. 相似文献
49.
50.
Birgitta Malmberg Göran Kecklund Björn Karlson Roger Persson Per Flisberg Palle Ørbaek 《BMC health services research》2010,10(1):239